Surmodics, Inc. (SRDX)

NASDAQ: SRDX · IEX Real-Time Price · USD
19.02
+0.79 (4.33%)
Jun 2, 2023, 4:00 PM EDT - Market closed
4.33%
Market Cap 268.81M
Revenue (ttm) 102.97M
Net Income (ttm) -35.96M
Shares Out 14.13M
EPS (ttm) -2.58
PE Ratio n/a
Forward PE 81.97
Dividend n/a
Ex-Dividend Date n/a
Volume 80,921
Open 18.53
Previous Close 18.23
Day's Range 18.36 - 19.03
52-Week Range 16.00 - 39.99
Beta 1.02
Analysts Buy
Price Target 60.00 (+215.46%)
Earnings Date Jul 26, 2023

About SRDX

Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to pr... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Mar 4, 1998
Employees 447
Stock Exchange NASDAQ
Ticker Symbol SRDX
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 2 analysts, the average rating for SRDX stock is "Buy." The 12-month stock price forecast is $60.0, which is an increase of 215.46% from the latest price.

Price Target
$60.0
(215.46% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Top 5 Health Care Stocks That Could Blast Off In May - Coherus BioSciences (NASDAQ:CHRS), Intercept Pharma (NASDAQ:ICPT)

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Other symbols: CHRSICPTVRAYYS
1 week ago - Benzinga

Surmodics to Participate in the Jefferies Healthcare Conference on June 8

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- #JefferiesHealthcareConference--Surmodics today announced that management will present at the Jefferies Healthcare Conference on Thursday, June 8, at 1:30 p.m. E...

1 week ago - Business Wire

Surmodics Reports Second Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- #ConferenceCall--Surmodics today reported financial results for its second quarter ended March 31, 2023, and updated its financial guidance for its fiscal year 2...

1 month ago - Business Wire
}

Surmodics Announces First Patient Enrolled in PROWL Registry Study Using the Pounce™ Thrombectomy System

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- #MedicalDevice--The PROWL registry will collect real-world efficacy and safety outcomes data for endovascular interventions using the Pounce thrombectomy system.

1 month ago - Business Wire

Surmodics to Report Second Quarter of Fiscal 2023 Financial Results on April 26

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- #ConferenceCall--Surmodics announced that second quarter of fiscal year 2023 financial results will be released before the market opens on Wednesday, April 26.

1 month ago - Business Wire

Surmodics Announces Successful First Patient Use of Sublime™ Radial Access Microcatheter Designed for the Periphery

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- #MedicalDevice--The new line of Surmodics' Sublime microcatheters rounds out a complete line of Sublime Radial Access Platform products.

1 month ago - Business Wire

Surmodics to Participate in the 22nd Annual Needham Virtual Healthcare Conference on April 20

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- #InVitroDiagnostic--Surmodics management will participate in investor meetings at the Needham Virtual Healthcare Conference and will present at 9:15 a.m. CT on A...

1 month ago - Business Wire

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation - SRDX

NEW YORK , March 31, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Surmodics Inc. (NASD...

2 months ago - PRNewsWire
}

Surmodics Provides Regulatory Update on its Strategy to Submit an Amended Premarket Approval Application for the SurVeil™ Drug-Coated Balloon

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that it has ...

2 months ago - Business Wire

ROSEN, A LEADING LAW FIRM, Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation - SRDX

NEW YORK , March 17, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Surmodics Inc. (NASD...

2 months ago - PRNewsWire

SRDX INVESTOR NOTICE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation - SRDX

NEW YORK , March 10, 2023 /PRNewswire/ --  WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Surmodics Inc. (NAS...

3 months ago - PRNewsWire

Surmodics to Participate in Upcoming Investor Conferences in March

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that managem...

3 months ago - Business Wire

NATIONALLY RANKED ROSEN LAW FIRM Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation - SRDX

NEW YORK , March 1, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Surmodics Inc. (NASDA...

3 months ago - PRNewsWire
}

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Surmodics, Inc. - SRDX

NEW YORK , Feb. 22, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Surmodics, Inc. ("Surmodics" or the "Company") (NASDAQ: SRDX). Such investors are advised to co...

3 months ago - PRNewsWire

ROSEN, Global Investor Counsel, Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation - SRDX

New York, New York--(Newsfile Corp. - February 17, 2023) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Sur...

3 months ago - Newsfile Corp

Surmodics Investigated by Block & Leviton for Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm

Boston, Massachusetts--(Newsfile Corp. - February 15, 2023) - Block & Leviton is investigating Surmodics, Inc. (NASDAQ: SRDX) for potential securities law violations. Investors who have lost money in ...

3 months ago - Newsfile Corp

SRDX INVESTOR NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation - SRDX

NEW YORK , Feb. 8, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of Surmodics Inc. (...

4 months ago - PRNewsWire

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Surmodics, Inc. and Encourages Investors with Losses to Contact the Firm

Los Angeles, California--(Newsfile Corp. - February 6, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of S...

4 months ago - Newsfile Corp

ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Surmodics, Inc. and Encourages Investors with Losses to Contact the Firm

Los Angeles, California--(Newsfile Corp. - February 3, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of S...

4 months ago - Newsfile Corp

ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Surmodics, Inc. and Encourages Investors with Losses to Contact the Firm

Los Angeles, California--(Newsfile Corp. - January 31, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of S...

4 months ago - Newsfile Corp

Surmodics to Host Virtual Annual Meeting of Shareholders

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, will hold its Annual Meeti...

4 months ago - Business Wire

Surmodics Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm

Boston, Massachusetts--(Newsfile Corp. - January 30, 2023) - Block & Leviton is investigating Surmodics, Inc. (NASDAQ: SRDX) for potential securities law violations. Investors who have lost money in t...

4 months ago - Newsfile Corp

ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Surmodics, Inc. and Encourages Investors with Losses to Contact the Firm

Los Angeles, California--(Newsfile Corp. - January 30, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of S...

4 months ago - Newsfile Corp

INVESTIGATION NOTICE: The Schall Law Firm Announces It is Investigating Claims Against Surmodics, Inc. and Encourages Investors with Losses to Contact the Firm

Los Angeles, California--(Newsfile Corp. - January 27, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of S...

4 months ago - Newsfile Corp

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Surmodics, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / January 26, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Surmodics, Inc...

4 months ago - Accesswire